Securing Gene Synthesis Act

The Securing Gene Synthesis Act (S 2400) requires gene synthesis providers (companies creating custom DNA/RNA) and manufacturers of gene synthesis equipment to implement screening protocols to detect potential misuse of synthetic genetic material. It mandates that these entities be verified for compliance, with federal funding tied to adherence - non-compliant entities risk funding revocation. The bill defines key terms like "gene synthesis product" (excluding basic chemicals or sequencing byproducts) and sets a 2026 deadline for federal agencies to report compliance policies. This directly affects providers and equipment makers by imposing new screening and verification obligations under federal health law.